Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancer Research and Treatment|January 16, 2024
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World DataJeong Yun Jang, Si Yeol Song, Young Seob Shin, et al.
BMB Reports|December 29, 2018
HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cellsKang-Seo Park, Yong Sang Hong, Junyoung Choi, et al.
Neuro-Oncology|August 23, 2024
Mapping tumor habitats in isocitrate dehydrogenase -wild type glioblastoma: Integrating MRI, pathologic, and RNA data from the Ivy Glioblastoma Atlas ProjectJi Eun Park, Joo Young Oh, Do Hoon Park, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2019
Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomised phase II study (COACH, KCSG GU10-16)Inkeun Park, Bong-Seog Kim, Ho Yeong Lim, et al.
Anticancer Research|May 31, 2015
Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric CancerJin Young Kim, Hun Mo Ryoo, Sung Hwa Bae, et al.
Translational Lung Cancer Research|January 9, 2026
Exon-level <i>TP53</i> alterations and PD-L1 expression identified by pretreatment NGS stratify survival in <i>EGFR</i>-mutant non-small cell lung cancer treated with first-line osimertinibSeong-Eun Kim, Yongjae Kim, Do Kyung Yoon, et al.
JAMA Network Open|February 9, 2024
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South KoreaHyun Ae Jung, Dae Ho Lee, Sun Min Lim, et al.
Cellular and Molecular Life Sciences : CMLS|August 20, 2025
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokinesHyun-Min Ryu, Deokhoon Kim, Jun Young Choi, et al.
Oncotarget|October 21, 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab eraSeyoung Seo, Jung Yong Hong, Shinkyo Yoon, et al.
Plos One|August 13, 2019
Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical centerKyoungmin Lee, So Jung Lee, Shinkyo Yoon, et al.
Pageof 9